[Prevalence of hepatitis C virus infection among chronic hemodialysis patients].
Tuyuguchi
Masako
M
Gastroenterology Department, Sapporo Hokuyu Hospital.
Saitou
Masao
M
Kukita
Kazutaka
K
Kawamura
Akio
A
D000998:Antiviral Agents / Q000008:administration & dosage; D015415:Biomarkers / Q000032:analysis; D002908:Chronic Disease; D016174:Hepacivirus / Q000235:genetics; D006526:Hepatitis C / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D018937:Hepatitis C Antibodies / Q000032:analysis; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage; D015995:Prevalence; D012367:RNA, Viral / Q000032:analysis; D006435:Renal Dialysis / Q000009:adverse effects*; D012254:Ribavirin / Q000008:administration & dosage; D012306:Risk; D013997:Time Factors; D065227:Transfusion Reaction
D000998:Antiviral Agents; D015415:Biomarkers; D018937:Hepatitis C Antibodies; D016898:Interferon-alpha; D012367:RNA, Viral; D012254:Ribavirin